Literature DB >> 2565759

Anorexia nervosa and bulimia nervosa.

D S Goldbloom1, S H Kennedy, A S Kaplan, D B Woodside.   

Abstract

No definitive therapy exists for anorexia nervosa (AN) or bulimia nervosa (BN). Nevertheless, biologic and psychologic research into these disorders has increased over the last decade. We examine the various drugs available for treatment. Advances in pharmacotherapy for AN have been modest and have reflected efforts either to stimulate hunger and weight gain or to control complications of the starvation process. Food remains the "drug" of choice. Antidepressants have been found to be beneficial in the treatment of BN. The meaning of this in the context of a relation between BN and mood disorders remains unclear, since coexistent depression does not predict a positive response to these drugs. Pharmacotherapy represents a single but important dimension of the management of patients with eating disorders. The optimal integration of drug therapy and psychotherapy and the identification of predictors of a positive response to drugs have yet to be addressed by clinical research.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2565759      PMCID: PMC1269054     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  36 in total

1.  Bulimia in college women: incidence and recovery rates.

Authors:  A Drewnowski; D K Yee; D D Krahn
Journal:  Am J Psychiatry       Date:  1988-06       Impact factor: 18.112

2.  A controlled trial of d-fenfluramine in bulimia nervosa.

Authors:  G F Russell; S A Checkley; J Feldman; I Eisler
Journal:  Clin Neuropharmacol       Date:  1988       Impact factor: 1.592

3.  The use of opiate antagonists in treating bulimia: a study of low-dose versus high-dose naltrexone.

Authors:  J M Jonas; M S Gold
Journal:  Psychiatry Res       Date:  1988-05       Impact factor: 3.222

Review 4.  Outcome in anorexia nervosa and bulimia nervosa. A review of the literature.

Authors:  D B Herzog; M B Keller; P W Lavori
Journal:  J Nerv Ment Dis       Date:  1988-03       Impact factor: 2.254

5.  An evaluation of family therapy in anorexia nervosa and bulimia nervosa.

Authors:  G F Russell; G I Szmukler; C Dare; I Eisler
Journal:  Arch Gen Psychiatry       Date:  1987-12

6.  Treatment of bulimia with desipramine: a double-blind crossover study.

Authors:  J Barlow; J Blouin; A Blouin; E Perez
Journal:  Can J Psychiatry       Date:  1988-03       Impact factor: 4.356

7.  Clomipramine and 'drive' in people with anorexia nervosa: an in-patient study.

Authors:  A H Crisp; J H Lacey; M Crutchfield
Journal:  Br J Psychiatry       Date:  1987-03       Impact factor: 9.319

8.  A placebo-controlled crossover study of oral clonidine in acute anorexia nervosa.

Authors:  R C Casper; R F Schlemmer; J I Javaid
Journal:  Psychiatry Res       Date:  1987-03       Impact factor: 3.222

9.  Delayed gastric emptying in anorexia nervosa is improved by completion of a renutrition program.

Authors:  D Rigaud; G Bedig; M Merrouche; M Vulpillat; S Bonfils; M Apfelbaum
Journal:  Dig Dis Sci       Date:  1988-08       Impact factor: 3.199

10.  Radionuclide gastric emptying studies in patients with anorexia nervosa.

Authors:  P A Domstad; W J Shih; L Humphries; F H DeLand; G A Digenis
Journal:  J Nucl Med       Date:  1987-05       Impact factor: 10.057

View more
  4 in total

1.  Eating disorders and alcohol misuse: features of an addiction spectrum.

Authors:  F J Dunne; S Feeney; J Schipperheijn
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

Review 2.  The ethics of forced feeding in anorexia nervosa.

Authors:  P C Hébert; M A Weingarten
Journal:  CMAJ       Date:  1991-01-15       Impact factor: 8.262

Review 3.  Current perspectives on drug therapies for anorexia nervosa and bulimia nervosa.

Authors:  S H Kennedy; D S Goldbloom
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

Review 4.  Integrating clinical and research psychiatry.

Authors:  J M de Groot; S H Kennedy
Journal:  J Psychiatry Neurosci       Date:  1995-03       Impact factor: 6.186

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.